Nebula Research & Development LLC Grows Stake in Maximus, Inc. (NYSE:MMS)

Nebula Research & Development LLC boosted its stake in Maximus, Inc. (NYSE:MMS) by 3.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,004 shares of the health services provider’s stock after buying an additional 534 shares during the quarter. Nebula Research & Development LLC’s holdings in Maximus were worth $1,269,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Barclays PLC lifted its position in shares of Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock valued at $15,927,000 after acquiring an additional 126,573 shares in the last quarter. Virtu Financial LLC purchased a new position in Maximus in the 3rd quarter valued at $319,000. World Investment Advisors LLC lifted its holdings in Maximus by 6.6% in the 3rd quarter. World Investment Advisors LLC now owns 5,289 shares of the health services provider’s stock valued at $493,000 after purchasing an additional 326 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its stake in Maximus by 3.3% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 66,805 shares of the health services provider’s stock worth $6,224,000 after purchasing an additional 2,164 shares during the last quarter. Finally, Tidal Investments LLC grew its holdings in shares of Maximus by 49.1% during the third quarter. Tidal Investments LLC now owns 20,674 shares of the health services provider’s stock worth $1,926,000 after buying an additional 6,809 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on MMS shares. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd. StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

Maximus Trading Down 1.6 %

Shares of MMS opened at $67.72 on Friday. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The firm has a market capitalization of $3.83 billion, a P/E ratio of 14.56 and a beta of 0.68. The firm has a 50-day moving average price of $67.65 and a 200 day moving average price of $74.50. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.77%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.